P777 DOSE-DEPENDENT PHARMACOKINETICS FOR MK-5172 25 mg, 50 mg, AND 100 mg ONCE-DAILY FOR 12 WEEKS IN HCV GENOTYPE 1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS

✍ Scribed by Caro, L.; Talaty, J.; Morrison, M.; Zhang, S.; Guo, Z.; Gendrano III, I.N.; Hwang, P.; Mobashery, N.

• Book ID: 122264821
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 61 KB
• Volume: 60
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(14)60938-7